Share Email Print
cover

Proceedings Paper

Non-ablative hyperthermic mesenchymal regeneration: a proposed mechanism of action based on the Viveve model
Author(s): Jeffrey A. Vos; Ryan H. Livengood; Morris Jessop; James E. Coad
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Novel non-ablative hyperthermic medical devices are currently being developed, in association with cryogen surface cooling, to rejuvenate tissues without collagen scarring. These devices have been designed to remodel skin, manage urinary stress incontinence, and more recently, treat vaginal laxity. In contrast to the thermal injury and reparative healing associated with higher energy ablation systems, these lower energy non-ablative systems are designed to subtly modify the collagen, stimulate the fibroblasts, and maintain a functional tissue architecture that subsequently promotes tissue rejuvenation and restoration. While these devices have primarily relied on clinical outcome questionnaires and satisfaction surveys to establish efficacy, a physiologic explanation for the induced tissue changes and tightening has not been well documented. Recent histology studies, using the Viveve ovine vaginal treatment model, have identified changes that propose both a mechanism of action and a tissue remodeling timeline for such non-ablative hyperthermic devices. The Viveve model results are consistent with subtle connective tissue changes leading to fibroblast stimulation and subsequent collagen replacement and augmentation. Unlike tissue ablation devices that cause thermal necrosis, these non-ablative devices renew the targeted tissue without dense collagenous scarring over a period of 3 or more months. The spectrum of histologic findings, as illustrated in the Viveve ovine vaginal model, further support the previously documented safety and efficacy profiles for low-dose non-ablative hyperthermic devices that rejuvenate and tighten submucosal tissues.

Paper Details

Date Published: 22 February 2011
PDF: 8 pages
Proc. SPIE 7901, Energy-based Treatment of Tissue and Assessment VI, 790104 (22 February 2011); doi: 10.1117/12.876859
Show Author Affiliations
Jeffrey A. Vos, West Virginia Univ. (United States)
Ryan H. Livengood, West Virginia Univ. (United States)
Morris Jessop, West Virginia Univ. (United States)
James E. Coad, West Virginia Univ. (United States)


Published in SPIE Proceedings Vol. 7901:
Energy-based Treatment of Tissue and Assessment VI
Thomas P. Ryan, Editor(s)

© SPIE. Terms of Use
Back to Top